Drug and Alcohol Findings. (2016) Clonidine trialled in new anti-relapse role for heroin dependence. Drug and Alcohol Findings Research Analysis, (11 April 2016),
Preview | Title | Contact |
---|---|---|
|
PDF (Clonadine analysis)
80kB |
External website: http://findings.org.uk/PHP/dl.php?file=Kowalczyk_W...
From the USA the first study to show that the drug clonidine can not only ease withdrawal from heroin but also help prevent relapse, seemingly by moderating stress-related craving for the drug.
Key points from summary and commentary
• Clonidine is a medication commonly used to ease heroin withdrawal, but it may also help prevent resumption of heroin use by avoiding stress-related craving for the drug.
• The first study to test this theory found that buprenorphine-maintained patients allocated at random to clonidine were on some measures less likely to use illicit opiate-type drugs and less likely to experience craving for heroin associated with stress or poor mood.
• This single study has not yet established that in routine practice clonidine will prove useful in this new role; in other circumstances patients may simply not take the pills.
A Substance use and dependence > Personal history of substance use (pathway) > Relapse / Recurrence
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Heroin
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug withdrawal / craving
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
VA Geographic area > United States
Repository Staff Only: item control page